Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | TLR2 | O60603 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 6/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27525565 | 1.00 | CNR2 (0.50) | CNR2TRPV1NAAAEPHX1CNR1 | |
| SCHEMBL15282090 | 0.91 | CNR2 (0.45) | CNR2TRPV1NAAAEPHX1CNR1 | |
| SCHEMBL27385830 | 0.86 | CNR2 (0.57) | CNR2TRPV1NAAAEPHX1CNR1 | |
| SCHEMBL3758968 | 0.86 | CNR2 (0.66) | CNR2TRPV1EPHX1CNR1CES2 | |
| SCHEMBL11778607 | 0.84 | CNR2 (0.47) | CNR2TRPV1NAAAEPHX1CNR1 | |
| SCHEMBL9281603 | 0.83 | CNR2 (0.54) | CNR2TRPV1NAAAEPHX1CNR1 | |
| SCHEMBL839806 | 0.82 | — | — | |
| SCHEMBL11779331 | 0.82 | CNR2 (0.45) | CNR2TRPV1NAAAEPHX1CNR1 | |
| SCHEMBL28144752 | 0.82 | CNR2 (0.53) | CNR2TRPV1NAAAEPHX1CNR1 | |
| SCHEMBL8516233 | 0.81 | EPHX1 (0.48) | CNR2TRPV1NAAAEPHX1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090192192-A1 | INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA | TOUCH BIONICS LIMITED (GB) | 2009-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090192192-A1 | INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA | PGLS, TFPI, Q6ZSR9 | CNR2 2632/4885TRPV1 462/4885NAAA 213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.